Skip to content

A randomised controlled trial investigating the role of subfascial endoscopic perforator vein surgery (SEPS) in the prevention of recurrence in recurrent long saphenous varicose veins

A randomised controlled trial investigating the role of subfascial endoscopic perforator vein surgery (SEPS) in the prevention of recurrence in recurrent long saphenous varicose veins

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77323728
Enrollment
Unknown
Registered
2003-09-12
Start date
2000-09-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Recurrent long saphenous varicose veins Circulatory System Varicose veins of lower extremities

Interventions

Randomised controlled trial randomised into two groups: Group 1: subfascial endoscopic perforator vein surgery (SEPS) Group 2: standard open procedure

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with recurrent varicose veins, undergoing surgery, with Duplex proven incompetent perforating veins

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Improvement in function measured by refill time, incidence of recurrent reflux, clinical recurrence, and cosmetic results.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026